Cerebrospinal fluid cells immune landscape in multiple sclerosis.

Area of Science:

• Neuroimmunology
• Computational Biology
• Genomics

Background:

• Multiple Sclerosis (MS) is a debilitating autoimmune neurological disorder characterized by central nervous system (CNS) demyelination.
• Understanding the immune microenvironment during MS onset is crucial for developing effective treatments.

Purpose of the Study:

• To investigate alterations in immune cell proportions, gene expression, and related pathways in the CNS during Multiple Sclerosis (MS) onset.
• To identify core genes and molecular mechanisms associated with MS pathogenesis.

Main Methods:

• Utilized two independent datasets (E-MTAB-69, E-MTAB-2374) from the ArrayExpress database for derivation and validation.
• Applied CIBERSORT analysis to identify immune cell type alterations and differential gene expression analysis (FDR < 0.05, |log2FC| > 1) to find differentially expressed genes (DEGs).
• Performed functional enrichment analyses to explore MS-associated pathways.

Main Results:

• Significantly altered proportions of plasma cells, monocytes, macrophage M2, neutrophils, and eosinophils were observed in the cerebrospinal fluid (CSF) of MS patients compared to controls.
• Identified complement and coagulation cascades and systemic lupus erythematosus (SLE) pathways as potentially critical in MS.
• Eight core genes (NLRP3, LILRB2, C1QB, CD86, C1QA, CSF1R, IL1B, TLR2) correlated with MS were identified.

Conclusions:

• The study successfully characterized changes in the CNS immune microenvironment in MS using in silico data analysis.
• Findings provide insights into the molecular mechanisms of MS and suggest potential therapeutic targets for future interventions.